✦ LIBER ✦

PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal Cancer

✍ Scribed by Ubago, R.; Castillo, M.A.; Flores, S.; Rodriguez, R.; Beltran, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab adds benefit in first-line tre

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

PCN19 COST EFFECTIVENESS OF CETUXIMAB IN

✍ D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN118 COST EFFECTIVENESS OF CETUXIMAB I

✍ SG Eggington; D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCN71 Cost-Effectiveness Analysis of Cet

✍ V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN11 Bevacizumab in Combination with Ch

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Beltrán, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cetuximab plus XELIRI or XELOX for First

✍ Nicolas Moosmann; Volker Heinemann 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 121 KB